| . | CAS/CABG (n = 10) . | CEA/CABG (n = 10) . | P-value . |
|---|---|---|---|
| Age | 65 ± 7 | 70 ± 7 | 0.191 |
| Male (%) | 8 (80) | 5 (50) | 0.350 |
| Hypertension (%) | 9 (90) | 8 (80) | 0.763 |
| Diabetes (%) | 1 (10) | 4 (40) | 0.303 |
| Previous myocardial infarction (%) | 5 (50) | 7 (70) | 0.650 |
| Peripheral vascular disease (%) | 2 (20) | 6 (60) | 0.170 |
| NYHA class | 2.3 ± 0.5 | 1.8 ± 0.7 | 0.218 |
| EuroSCORE | 2.8 ± 2.0 | 3.6 ± 2.3 | 0.547 |
| Left ventricular ejection fraction (%) | 44.3 ± 12.4 | 43.4 ± 13.3 | 0.896 |
| Carotid stenosis (%) | 79 ± 12 | 87 ± 13 | 0.224 |
| Bilateral carotid disease | 4 (40) | 5 (50) | 0.974 |
| Previous stroke/transitory ischaemic attack | 2 (20) | 3 (30) | 0.962 |
| . | CAS/CABG (n = 10) . | CEA/CABG (n = 10) . | P-value . |
|---|---|---|---|
| Age | 65 ± 7 | 70 ± 7 | 0.191 |
| Male (%) | 8 (80) | 5 (50) | 0.350 |
| Hypertension (%) | 9 (90) | 8 (80) | 0.763 |
| Diabetes (%) | 1 (10) | 4 (40) | 0.303 |
| Previous myocardial infarction (%) | 5 (50) | 7 (70) | 0.650 |
| Peripheral vascular disease (%) | 2 (20) | 6 (60) | 0.170 |
| NYHA class | 2.3 ± 0.5 | 1.8 ± 0.7 | 0.218 |
| EuroSCORE | 2.8 ± 2.0 | 3.6 ± 2.3 | 0.547 |
| Left ventricular ejection fraction (%) | 44.3 ± 12.4 | 43.4 ± 13.3 | 0.896 |
| Carotid stenosis (%) | 79 ± 12 | 87 ± 13 | 0.224 |
| Bilateral carotid disease | 4 (40) | 5 (50) | 0.974 |
| Previous stroke/transitory ischaemic attack | 2 (20) | 3 (30) | 0.962 |
CAS/CABG: carotid artery stenting/coronary artery bypass grafting; CEA/CABG: carotid eversion endarterectomy/coronary artery bypass grafting.
| . | CAS/CABG (n = 10) . | CEA/CABG (n = 10) . | P-value . |
|---|---|---|---|
| Age | 65 ± 7 | 70 ± 7 | 0.191 |
| Male (%) | 8 (80) | 5 (50) | 0.350 |
| Hypertension (%) | 9 (90) | 8 (80) | 0.763 |
| Diabetes (%) | 1 (10) | 4 (40) | 0.303 |
| Previous myocardial infarction (%) | 5 (50) | 7 (70) | 0.650 |
| Peripheral vascular disease (%) | 2 (20) | 6 (60) | 0.170 |
| NYHA class | 2.3 ± 0.5 | 1.8 ± 0.7 | 0.218 |
| EuroSCORE | 2.8 ± 2.0 | 3.6 ± 2.3 | 0.547 |
| Left ventricular ejection fraction (%) | 44.3 ± 12.4 | 43.4 ± 13.3 | 0.896 |
| Carotid stenosis (%) | 79 ± 12 | 87 ± 13 | 0.224 |
| Bilateral carotid disease | 4 (40) | 5 (50) | 0.974 |
| Previous stroke/transitory ischaemic attack | 2 (20) | 3 (30) | 0.962 |
| . | CAS/CABG (n = 10) . | CEA/CABG (n = 10) . | P-value . |
|---|---|---|---|
| Age | 65 ± 7 | 70 ± 7 | 0.191 |
| Male (%) | 8 (80) | 5 (50) | 0.350 |
| Hypertension (%) | 9 (90) | 8 (80) | 0.763 |
| Diabetes (%) | 1 (10) | 4 (40) | 0.303 |
| Previous myocardial infarction (%) | 5 (50) | 7 (70) | 0.650 |
| Peripheral vascular disease (%) | 2 (20) | 6 (60) | 0.170 |
| NYHA class | 2.3 ± 0.5 | 1.8 ± 0.7 | 0.218 |
| EuroSCORE | 2.8 ± 2.0 | 3.6 ± 2.3 | 0.547 |
| Left ventricular ejection fraction (%) | 44.3 ± 12.4 | 43.4 ± 13.3 | 0.896 |
| Carotid stenosis (%) | 79 ± 12 | 87 ± 13 | 0.224 |
| Bilateral carotid disease | 4 (40) | 5 (50) | 0.974 |
| Previous stroke/transitory ischaemic attack | 2 (20) | 3 (30) | 0.962 |
CAS/CABG: carotid artery stenting/coronary artery bypass grafting; CEA/CABG: carotid eversion endarterectomy/coronary artery bypass grafting.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
